[1]
“Formulation and in-vitro Evaluation of Oro-dispersible tablets of Indomethacin”, Nep. J. Health Sci., vol. 2, no. 1, pp. 90–97, Aug. 2022, doi: 10.3126/njhs.v2i1.47172.